NorA efflux pump (NorA)

The NorA efflux pump is a proton-dependent transporter belonging to the major facilitator superfamily, most notably found in *Staphylococcus aureus*. NorA is a canonical multidrug efflux system responsible for extruding a broad spectrum of compounds—including fluoroquinolone antibiotics, such as ciprofloxacin—across the bacterial inner membrane, resulting in decreased intracellular drug concentration and enhanced antimicrobial resistance. Structural studies have revealed that NorA coordinates drug/proton antiport via essential acidic residues (Glu222, Asp307), enabling antibiotic extrusion in exchange for protons. Overexpression of norA not only mediates immediate resistance mechanisms but also facilitates rapid genetic adaptation to antibiotic stress, promoting the development of additional resistance mutations in target enzymes (e.g., topoisomerase IV, DNA gyrase). NorA is a validated drug target for efflux pump inhibitors (EPIs), which can restore antibiotic susceptibility and delay the evolution of high-level resistance in laboratory and animal models. Therapeutic strategies targeting NorA are actively pursued to counteract multidrug-resistant *S. aureus*.

Other names

NorANorA transporterNorA multidrug efflux pump

Substrate (antibiotic) extrusion by proton-coupled antiport — NorA couples proton import with drug extrusion, decreasing intracellular antibiotic concentration and facilitating resistance. Drugs that target NorA function as efflux pump inhibitors (EPIs), blocking substrate binding or transporter conformational transitions, thereby restoring antibiotic susceptibility.